LEADER 01494nam  2200397Ia 450 
001 9910699117403321
005 20230902162108.0
035   $a(CKB)5470000002400725
035   $a(OCoLC)465468448
035   $a(EXLCZ)995470000002400725
100   $a20091113d2003      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $epowder blends and finished dosage units : stratified in-process dosage unit sampling and assessment
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2003]
215   $a1 online resource (15 pages) $ccharts
300   $a"Draft guidance."
300   $a"Pharmaceutical CGMPs."
300   $a"October 2003."
517   $aGuidance for industry 
606   $aPowders (Pharmacy)$xSampling$xGovernment policy$zUnited States
606   $aPowders (Pharmacy)$xEvaluation$xGovernment policy$zUnited States
606   $aDrugs$xDosage forms
615  0$aPowders (Pharmacy)$xSampling$xGovernment policy
615  0$aPowders (Pharmacy)$xEvaluation$xGovernment policy
615  0$aDrugs$xDosage forms.
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699117403321
996   $aGuidance for industry$93434577
997   $aUNINA